Felypressin-induced reduction in coronary blood flow and myocardial tissue oxygen tension during anesthesia in dogs

Canadian Journal of Anaesthesia

Volumn 46, Issue 11, 1999, Pages 1070-1075

  Agata, Hideharu ^a   Ichinohe, Tatsuya ^a   Kaneko, Yuzuru ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FELYPRESSIN; ISOFLURANE; NITROUS OXIDE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; FEMALE; HEART; HEART RATE; INFUSION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; MALE; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN SUPPLY; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL;

EID: 0033452808     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03013205     Document Type: Article

References (20)

1. Yagiela JA. Vasoconstrictor agents for local anesthesia. Anesth Prog 1995; 42: 116-20.
2. El-Din ASMAK, Mostafa SM. Severe hypertension during anaesthesia for dacryocystorhinostmy. Anaesthesia 1985; 40: 787-9.
3. Himuro H, Aono K, Honda T, Nakajima T, Ohara G. A case of coronary artery spasm during oral surgery under general anesthesia. Anesth Pain Control Dent 1992; 1: 215-8.
4. Martin JD, Shenk LG. Intraoperative myocardial infarction after paracervical vasopresssin infiltration. Anesth Analg 1994; 79: 1201-2.
5. Jackson EK. Vasopressin and other agents affecting the renal conservation of water. In: Hardman JG, Limbird LE (Eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. New York: MacGraw-Hill, 1996: 715-31.
6. Kitagawa E. The effects of intravenously injected felypressin on cardiac function in dogs with intact or ischemic hearts. Anesth Prog 1995; 42: 154-5.
7. Kissin I, Reves JG, Mardis M. Is the rate-pressure product a misleading guide? (Letter) Anesthesiology 1980; 52: 373-4.
8. Share L. Role of vasopressin in cardiovascular regulation. Physiol Rev 1988; 68: 1248-84.
9. Tsakiris A, Bühlmann A. Experimentelle untersuchngen beim menschen über die wirkung von vasopressin auf die leberdurchblutung und den portalen druck. Helv Med Acta 1961; 28: 615-21.
10. Saito T, Matsuzaki T, Wakisaka K, etal. Problems and precautions in the application of octapressin. (Japanese) Masui 1966; 15: 1089-94.
11. Hof RP. Vasopressin induced myocardial depression is neurally mediated and not due to impaired coronary blood flow. Br J Pharmacol 1986; 87: 611-8.
12. Tipayamontri U, Young DB, Nuwayhid BS, Scott RE. Analysis of the cardiovascular effects of arginine vasopressin in conscious dogs. Hypertension 1987; 9: 371-8.
13. Graf BM, Fischer B, Martin E, Bonsjak ZJ, Stowe DF. Differential effects of arginine vasopressin on isolated guinea pig heart function during perfusion at constant flow and constant pressure. J Cardiovasc Pharmacol 1997; 29: 1-7.
14. Yokoyama, M, Maekawa K, Katada Y, et al. Effects of graded coronary constriction on regional oxygen and carbon dioxide tensions in outer and inner layers of the canine myocardium. Jpn Circ J 1978; 42: 701-9.
15. Guyaton AC, Hall JE. Muscle blood flow and cardiac output during exercise; the coronary circulation and ischemic heart disease. In: Guyaton AC, Hall JE (Eds.). Text Book of Medical Physiology, Philadelphia: W.B. Saunders Company, 1996: 253-63.
16. Kohno M, Horio T, Ikeda M, et al. Natriuretic peptides inhibit mesangial cell production of endothelin induced by arginine vasopressin. Am J Physiol 1993; 264: F678-83.
17. Godfraind T. Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br J Pharmacol 1993; 110: 1201-5.
18. Priebe H-J. Isoflurane and coronary hemodynamics. Anesthesiology 1989; 71: 960-76.
19. Nathan HJ. Nitrous oxide worsens myocardial ischemia in isoflurane-anesthetized dogs. Anesthesiology 1988; 68: 407-15.
20. Ichinohe T, Kaneko Y, Nakakuki T. The effect of epinephrine on circulation and respiration - a study on epinephrine infusion technique. Dentistry in Japan 1991; 28: 161-5.